Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2025-12-24 @ 10:47 PM
NCT ID:
NCT00197769
Eligibility Criteria:
Inclusion Criteria:
* Informed consent by parent/guardian for receipt of study vaccines and for blood samples
* Age at first dose: Infants 7-11 weeks; toddlers 12-18 months
Exclusion Criteria:
* Previous bacteriologically confirmed pneumococcal or meningococcal disease
* Contraindications for pneumococcal, meningococcal, Hib, DTP, MMR immunisations as listed in the UK handbook, "Immunisation Against Infectious Disease" Edition 1996.
* Language difficulty in parents sufficient to preclude adequate comprehension of the information sheet, consent form and study nurses' explanation of the study
* Children participating in any other clinical trial
* Immunocompromised
* Acute systemic illness or fever \> 38C on day of vaccination - deferral
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
7 Weeks
Maximum Age:
18 Months
Study:
NCT00197769
Study Brief:
Protocol Section:
NCT00197769